The Senate defeated an amendment that would have let Americans buy drugs from Canadian pharmacies.<\/p>\n
The chamber voted down the amendment, sponsored by Sen. John McCain (R-Ariz.), in a vote of 43-54. The vote had a 60-vote threshold.<\/p>\n
Prior to the amendment\u2019s defeat McCain blamed the pharmaceutical industry for pressuring the Senate to defeat the legislation.<\/p>\n
\u201cIn a normal world this would probably require a voice vote, but what we\u2019re about to see is the incredible influence of the special interests, particularly pharma, here in Washington, that keeps people who cannot \u2014 that have to make a choice between eating and medicine,\u201d McCain said. \u201cSo what you\u2019re about to see is the reason for the cynicism that people have for the way we do things in Washington. Pharma, one of the most powerful lobbies in Washington, will exert its influence again at the expense of average, low income Americans who, again, will have to choose between medication and eating.\u201d<\/p>\n
The vote came during a series of votes on amendments to a Food and Drug Administration reauthorization bill on Thursday. Thirty Republicans voted against the amendment.<\/p>\n
Sen. Charles Grassley (R-Iowa), a long-time supporter of allowing drug importation from Canada, spoke in favor of the McCain language Thursday morning.<\/p>\n
\u201cI have always considered drug importation a free-trade issue,\u201d Grassley said in his prepared remarks. \u201cImports create competition and keep domestic industry more responsive to consumers.<\/p>\n
\u201cIf Americans could legally and safely access prescription drugs outside the United States, then drug companies will be forced to re-evaluate their pricing strategies,\u201d he added. \u201cThey\u2019d no longer be able to gouge American consumers by making them pay more than their fair share of the high cost of research and development.\u201d<\/p>\n
A border-state senator, Olympia Snowe (R-Maine), agreed that McCain\u2019s amendment would help reduce costs for Americans.<\/p>\n
\u201cAmerican consumers are paying 50 percent higher costs for the same prescription drugs than Canadians do,\u201d she said. \u201cWe know for a fact that allowing drug importation generates considerable cost savings to the government, to individuals and businesses that provide health insurance coverage to their employees.\u201d<\/p>\n
But Sen. Mike Enzi (R-Wyo.) argued that the amendment would put the safety of Americans at risk, since it would let Canadian Internet pharmacies sell into the United States without any of the approval processes applied to U.S. drugs. \u201cWe\u2019re not talking about bus trips of seniors to reputable pharmacies right across the border,\u201d Enzi said.<\/p>\n
Enzi added that drugs from Canada would actually be from anywhere around the world, as Canadian pharmacies have acknowledged that they get most of their drugs from overseas.<\/p>\n
\u201cDrugs that supposedly come from Canada can really come from any place in the world and then are shipped from Canada,\u201d he said.
\nShortly after the McCain amendment\u2019s defeat, the Senate defeated one sponsored by Sen. Bernie Sanders (I-Vt.) which takes away a drug company\u2019s exclusive marketing rights if that company is found guilty of fraud. The Senate defeated Sanders\u2019s bill 9 to 88.<\/p>\n
The Senate also tabled an amendment by Sen. Dick Durbin (D-Ill.) which would have established a requirement that dietary supplement manufacturers to register with the FDA.<\/p>\n